Literature DB >> 15367567

Biomarker boom slowed by validation concerns.

Steven Benowitz.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15367567     DOI： 10.1093/jnci/96.18.1356

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Searching for 'omic' biomarkers.

Authors:  David Lin; Zsuzsanna Hollander; Anna Meredith; Bruce M McManus
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

2.  Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

Authors:  J Cummings; M Ranson; E Lacasse; J R Ganganagari; M St-Jean; G Jayson; J Durkin; C Dive
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

3.  Practical guide for identifying unmet clinical needs for biomarkers.

Authors:  Phillip J Monaghan; Sarah Robinson; Daniel Rajdl; Patrick M M Bossuyt; Sverre Sandberg; Andrew St John; Maurice O'Kane; Lieselotte Lennartz; Ralf Röddiger; Sarah J Lord; Christa M Cobbaert; Andrea R Horvath
Journal:  EJIFCC       Date:  2018-07-11

Review 4.  The cancer secretome: a reservoir of biomarkers.

Authors:  Hua Xue; Bingjian Lu; Maode Lai
Journal:  J Transl Med       Date:  2008-09-17       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.